For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
|
|
| Basic information |
| Chairman |
President |
Spokesperson |
Telephone |
Address |
ESM Registration Date |
| Joseph Chow |
Kevin Chiang |
- |
2696-1658 |
14F.,No.100,Sec.1,Xintai 5th Rd.,Xizhi Dist.,New Taipei City 221 .Taipei Taiwan |
2013/12/16 |
| Industrycategory |
Key businesses |
| Biotechnology and Medical Care |
Genomics BioScience and Technology Co., Ltd, is a bioscience and technology
company which was founded in 2001 by Prof. T. Y. Chow, who was a student of
Sanger and one of the leaders in IRGSP.Base on Genomics and metabolomics
technologies We have been committed to scientific
research, product development and various technical services. We can describe
our products as follow: research, application, health and clinical.
We’ll do our best to increase the growth of research market, clinical and
public market, expand the market of China and Asia, and develop the patent
of service and products. All we hope is to become one of the most state-of-the-
art biotech company in Taiwan. |
| Financial data |
| Cash flows statement
| Item
|
|
|
| Amount(NTD, in thousands) |
| Cash flows from operating activities |
|
|
| Cash flows from investing activities |
|
|
| Cash flows from financing activities |
|
|
Consolidated/Individual
balance sheet
|
Current assets |
|
|
| Non-current assets |
|
|
| Total assets |
|
|
| Current liabilities |
|
|
| Non-current liabilities |
|
|
| Total liabilities |
|
|
| Share capital |
|
|
| Capital surplus |
|
|
| Retained earnings |
|
|
| Other equity interest |
|
|
| Treasury shares |
|
|
| Total equity attributable to owners of parent |
|
|
| Non-controlling interests |
|
|
| Total equity |
|
|
| Book Value per share(NT$) |
|
|
Consolidated/Individual
profit and loss
statement |
Operating revenue |
|
|
| Operating costs |
|
|
| Gross profit from operations |
|
|
| Operating expenses |
|
|
| Net other income (expenses) |
|
|
| Net operating income |
|
|
| Non-operating income and expenses |
|
|
| Profit before tax |
|
|
| Tax expense |
|
|
| Profit from continuing operations |
|
|
| Profit from discontinued operations |
|
|
| Profit |
|
|
| Other comprehensive income |
|
|
| Comprehensive income |
|
|
| Basic earnings per share |
|
|
 Auditor's report on latest financial statements： auditor's report：
|
|
Investors may find more detailed information on the company by visiting the Market Observation Post System.。
|
|
The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.
|
